These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2859078)

  • 1. Comparison of different strategies for treatment of duodenal ulcer.
    Sonnenberg A
    Br Med J (Clin Res Ed); 1985 Apr; 290(6476):1185-7. PubMed ID: 2859078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of medical and surgical treatment of duodenal ulcer.
    Sonnenberg A
    Gastroenterology; 1989 Jun; 96(6):1445-52. PubMed ID: 2565844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Supraselective vagotomy. Long-term results in the treatment of duodenal ulcer].
    de Mestier P; Vallot T
    Presse Med; 1992 Jun; 21(22):1014-6. PubMed ID: 1354868
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of resistant duodenal ulcer].
    Vigneri S; Scialabba A; Pisciotta G; Termini R; Muratore F; Vinti M
    Minerva Med; 1989 Nov; 80(11):1205-10. PubMed ID: 2574838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgical and conservative treatment of uncomplicated duodenal ulcer].
    Pomelov VS; Ganzha PF
    Khirurgiia (Mosk); 1995; (3):56-8. PubMed ID: 7630091
    [No Abstract]   [Full Text] [Related]  

  • 6. Is antral gastrin important in the resistance of duodenal ulcers to H2 receptor antagonists or in recurrent ulceration after highly selective vagotomy?
    Primrose JN; Naik KS; Blackett RL; King RF; Holmfield JH; Lagopolous M; Johnston D
    Gut; 1990 Jul; 31(7):763-6. PubMed ID: 1973394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term effects of vagotomy and drainage, parietal cell vagotomy and H2 receptor antagonists on duodenal ulcers and gastric function and structure.
    Bank S; Marks IN; Louw JH
    S Afr Med J; 1980 Apr; 57(16):622-7. PubMed ID: 6103589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [10 years' results following proximal selective vagotomy in duodenal ulcer disease. A prospective study].
    Teichmann RK; Cappeller WA; Krämling HJ; Pratschke E
    Chirurg; 1985 Aug; 56(8):515-21. PubMed ID: 2864223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proximal gastric vagotomy without drainage and selective gastric vagotomy with drainage for surgical therapy of duodenal ulcer: a retrospective study.
    Forlini A; Spina C; Gentileschi G; Maggi O; Gentileschi E
    Ital J Surg Sci; 1983; 13(1):21-4. PubMed ID: 6603444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proximal gastric vagotomy versus long-term maintenance treatment with cimetidine for chronic duodenal ulcer: a prospective randomised trial.
    Gear MW
    Br Med J (Clin Res Ed); 1983 Jan; 286(6359):98-9. PubMed ID: 6401510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ulcus pepticum ventriculi et duodeni--medicamentous recurrence prevention versus operation. The internist--surgical controversy].
    Feurle GE; Becker HD
    Z Gastroenterol Verh; 1985 Apr; 20():22-7. PubMed ID: 2409697
    [No Abstract]   [Full Text] [Related]  

  • 12. Vagotomy for duodenal ulcer resistant to H2-receptor antagonists.
    Vassilakis JS; Xynos E; Mantidis A; Zoras OJ; Nikolopoulos N
    Digestion; 1989; 44(1):1-6. PubMed ID: 2574693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term H2 antagonists in peptic ulcer disease.
    Cooper GJ; Kerrigan DD; Johnson AG
    BMJ; 1988 Dec; 297(6663):1612. PubMed ID: 2906261
    [No Abstract]   [Full Text] [Related]  

  • 14. Failure of proximal gastric vagotomy for duodenal ulcer resistant to cimetidine.
    Hansen JH; Knigge U
    Lancet; 1984 Jul; 2(8394):84-6. PubMed ID: 6146018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the pre-operative response to H2 receptor antagonists on the outcome of highly selective vagotomy for duodenal ulcer.
    Goodman AJ; Kerrigan DD; Johnson AG
    Br J Surg; 1987 Oct; 74(10):897-9. PubMed ID: 2889503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcer recurrence, morbidity, and mortality after operations for duodenal ulcer.
    Trout HH
    Am J Surg; 1982 Nov; 144(5):570-2. PubMed ID: 7137466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indications and results of surgical treatment of ulcers. Considerations after the introduction of H2-receptor antagonists].
    Barner S; Waldmann D; Farthmann EH
    Fortschr Med; 1984 Jul; 102(25-26):692-6. PubMed ID: 6147305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly selective vagotomy and duodenal ulcers that fail to respond to H2 receptor antagonists.
    Primrose JN; Axon AT; Johnston D
    Br Med J (Clin Res Ed); 1988 Apr; 296(6628):1031-5. PubMed ID: 3130125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of duodenal ulcer recurrence. A new prospect].
    Soulé JC
    Presse Med; 1991 Mar; 20(10):465-70. PubMed ID: 1673786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of surgery in the treatment of duodenal ulcer].
    Picaud R; Caamano A
    J Chir (Paris); 1988 Apr; 125(4):283-8. PubMed ID: 2899084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.